Call for abstracts is now open.   Abstract submission can take place from 26 May 2026 - 26 July 2026.

Submit abstract

Word limit for abstracts is 350 words. Tables and images can be uploaded and are not included in the wordcount. Tables and images must be uploaded as PNG or JPG, and the width and height of the images are limited to a maximum of 1000 pixels.

The abstract system will guide you through the abstract template to make sure that all information is completed correctly. If you have any questions please contact hephiv-abstracts@kit-group.org or hephiv.rigshospitalet@regionh.dk

Abstract topics:
Abstract submissions from multiple research domains: clinical and community research, behavioral science, implementation science, operational research and public policy under the following themes in relation to testing and linkage to care and integrated testing for hepatitis/HIV/STI/TB  

Health & implementation science
•    Integrated testing programs for hepatitis/HIV/STI/TB 
•    Surveillance, monitoring and evaluation (M&E) related to integrated testing
•    Access to diagnostics and linkage to care
•    Combination prevention for hepatitis/HIV/STI/TB 
•    Post-exposure and pre-exposure prophylaxis (integration with combination prevention and opportunities for testing)
•    Information-communication Technologies (ICT) (e-health, M-health) used in relation to testing
•    New testing and re-testing strategies 
•    Self-testing and self-sampling strategies 

Society & Social-behavioral science
•    Intersecting stigmas and discrimination affecting HIV and Hepatitis Testing
•    Test seeking behavioral determinants
•    Monitoring the impact of stigma on testing update and linkage to care 
•    Stakeholder engagement – community and civil society engagement in testing 
•    Migrants/mobile populations – models of testing and linkage to care 
•    Engagement and re-engagement of LTFU – developing innovative testing programs

Clinical Research
•    Novel and integrated approaches to testing for hepatitis/HIV/STI/TB
•    Testing in health care settings specific to key populations
•    Indicator condition guided testing
•    Point-of-care diagnostics in clinical setting

Policy
•    Knowledge translation to policy and programming
•    Political and structural drivers and responses in addressing multiple vulnerabilities – testing and linkage to care
•    Political engagement to enhance HIV testing
•    Roles of different actors and organizational aspects of testing programs